Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction-Reference-Cited by-同舟云学术

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction

Published:2018-06 Issue: Volume:9 Page:119-129
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Fitzpatrick Zachary,Leborgne Christian,Barbon Elena,Masat Elisa,Ronzitti Giuseppe,van Wittenberghe Laetitia,Vignaud Alban,Collaud Fanny,Charles Séverine,Simon Sola Marcelo,Jouen Fabienne,Boyer Olivier,Mingozzi Federico

Funder

Genethon

European Union

FP7-PEOPLE-2012-CIG Career Integration Grant

ERC-2013-CoG Consolidator Grant

Bayer Early Career Investigator Award

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference47 articles.

1. Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy;Mount;Blood,2002

2. A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome;Ronzitti;Mol. Ther. Methods Clin. Dev.,2016

3. Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins;Nathwani;Mol. Ther.,2011

4. Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients;Le Guiner;Mol. Ther.,2014

5. Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B;Arruda;Blood,2010

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in mice;Journal of Translational Medicine;2024-09-05

2. The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review;Prenatal Diagnosis;2024-09

3. Identification and validation of novel engineered AAV capsid variants targeting human glia;Frontiers in Neuroscience;2024-08-13

4. Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer;Molecular Therapy;2024-07

5. Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders;Neurotherapeutics;2024-07